PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization.

Mouse / Wound

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22910418 ↗2012Reported benefit

Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization.

MouseWoundC57BL/6MaleLocal administration at the incisional site; a separate arm transplanted rosiglitazone-treated peritoneal macrophages into the incisional site

Model: Surgical incision producing postincisional pain

Local rosiglitazone significantly reduced heat and mechanical hypersensitivity and paw swelling, decreased M1 and increased M2 macrophage numbers at 24 h, raised M2-associated gene expression and lowered M1-associated gene expression. Transplantation of rosiglitazone-treated peritoneal macrophages…

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.